During NAFLD progression, the inflammatory mediators IL-6, IL-8, IL-1β and TNF-α are regulated by a critical nuclear transcription factor, NF-κB [19]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.